By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Miscellaneous metabolic agents > Zokinvy
Miscellaneous metabolic agents

Zokinvy

https://themeditary.com/drug/zokinvy-3738.html
Medically Reviewed by Judith Stewart, BPharm TheMediTary.Com | Reviewed: Jul 14, 2023  Additional Content by TheMediTary.Com

Generic name: lonafarnib [ loe-na-far-nib ]

Drug class: Miscellaneous metabolic agents

Dosage form: capsule

Availability: Prescription only

Pregnancy & Lactation: Risk data available

Brand names: Lonafarnib

Contents
Uses Warnings Before Taking Dosage Side effects Interactions
  • Zokinvy (Lonafarnib [ loe-na-far-nib ])-LNF 50-50 mg-Yellow-Capsule-shape Zokinvy 50 mg (LNF 50)
  • Zokinvy (Lonafarnib [ loe-na-far-nib ])-LNF 75-75 mg-Orange-Capsule-shape Zokinvy 75 mg (LNF 75)
  • View all images

What is Zokinvy?

Zokinvy a prescription medicine used in people with certain rare genetic conditions that cause premature and rapid aging. Lonafarnib is for use in adults and children at least 12 months old whose bodies have reached a certain size (a body surface area of 0.39 square meters).

Zokinvy is used to lower the risk of death in people with Hutchinson-Gilford Progeria Syndrome (HGPS).

Zokinvy is also used to treat certain types of Progeroid Laminopathies that are "processing-deficient."

This medicine is not for use in people with non-HGPS Progeroid Syndromes or with Progeroid Laminopathies that are "processing-proficient."

Warnings

Tell your doctor about all your current medicines and any you start or stop using. Many drugs can interact, and some drugs should not be used together.

Lonafarnib can harm your unborn baby. Females who are able to become pregnant should use effective birth control during treatment with Zokinvy.

It is not known if Zokinvy is safe and effective in children under 12 months of age.

How should I take Zokinvy

Take Zokinvy exactly as prescribed by your doctor. Follow all directions on your prescription label and read all medication guides or instruction sheets. Your doctor may occasionally change your dose.

Zokinvy is usually taken daily with morning and evening meals. Follow your doctor's dosing instructions very carefully.

Take this medicine with a full glass of water.

Swallow the capsule whole and do not crush, chew, break, or open it.

If you cannot swallow a capsule whole, open it and sprinkle the medicine into 1 to 2 teaspoons of Ora Blend SF, Ora-Plus, orange juice, or applesauce. Swallow the mixture within 10 minutes after mixing. Do not save it for later use.

Do not mix the contents of a Zokinvy capsule with grapefruit juice or Seville orange juice. Read and carefully follow any Instructions for Use provided with your medicine. Ask your doctor or pharmacist if you do not understand these instructions.

Lonafarnib doses are based on body surface area (height and weight). Your dose needs may change if you gain or lose weight or if you are still growing.

Your doctor may need to check your vision on a regular basis.

Store at room temperature away from moisture and heat.

Dosing information

Usual Adult Dose for Hutchinson-Gilford Syndrome:

Initial dose: 115 mg/m2 orally twice a day
-After 4 months increase to 150 mg/m2 orally twice a day
Maintenance dose: 115 mg/m2 or 150 mg/m2 twice a day.

Usual Pediatric Dose for Hutchinson-Gilford Syndrome:

12 months and older with a Body Surface Area (BSA) of 0.39 m2 and above:

Initial dose: 115 mg/m2 orally twice a day
-After 4 months increase to 150 mg/m2 orally twice a day
Maintenance dose: 115 mg/m2 or 150 mg/m2 twice a day

Comments:
-The total daily dose should be rounded to the nearest 25 mg increment.
-For patients unable to tolerate a dose of 150 mg/m2 twice a day due to repeated episodes of vomiting and/or diarrhea resulting in dehydration or weight loss, may decrease dose to 115 mg/m2.

-Limitations of Use: Not indicated for other Progeroid Syndromes or processing-proficient Progeroid Laminopathies since based upon its mechanism of action, it would not be expected to be effective.

Uses:
-To reduce the risk of mortality in Hutchinson-Gilford Progeria Syndrome (HGPS).
-For the treatment of processing deficient Progeroid Laminopathies with either:
--Heterozygous LMNA mutation with progerin-like protein accumulation
--Homozygous or compound heterozygous ZMPSTE24 mutations.

Detailed Zokinvy dosage information
Zokinvy Dosage information (more detail)

Before Taking

You should not use Zokinvy if you are also using certain other medicines.

Many drugs can interact and cause dangerous effects. Some drugs should not be used together with Zokinvy. Your doctor may change your treatment plan if you also use:

  • midazolam;

  • St. John's wort;

  • phenobarbital or other barbiturate medicine;

  • an antibiotic or antifungal medicine;

  • antiviral medicine to treat HIV or hepatitis C;

  • cancer medicine;

  • cholesterol medicine (atorvastatin, lovastatin, or simvastatin);

  • heart or blood pressure medicine;

  • seizure medicine; or

  • steroid medicine.

You may need to stop using Zokinvy for 10 to 14 days before and 2 days after using certain other medicines. Do not stop taking Zokinvy without your doctor's advice.

To make sure Zokinvy is safe for you, tell your doctor if you have ever had:

  • kidney disease; or

  • eye problems.

Lonafarnib may harm an unborn baby. Use effective birth control to prevent pregnancy, and tell your doctor if you become pregnant.

This medicine may affect fertility (ability to have children) in both men and women. However, women should still use birth control to prevent pregnancy because lonafarnib can harm an unborn baby.

It may not be safe to breastfeed while using this medicine. Ask your doctor about any risk.

Zokinvy pregnancy and breastfeeding warnings (more detail)

What happens if I miss a dose?

Take the medicine as soon as you can, but skip the missed dose if your next dose is due in less than 8 hours. Do not take two doses at one time.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

What should I avoid while using Zokinvy?

Grapefruit and Seville oranges may interact with lonafarnib and lead to unwanted side effects. Avoid the use of grapefruit products and orange marmalades.

Zokinvy side effects

Get emergency medical help if you have signs of an allergic reaction to Zokinvy: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have:

  • new or worsening vision problems (such as decreased night vision);

  • severe ongoing nausea, vomiting, diarrhea;

  • loss of appetite that causes weight loss;

  • high blood pressure - severe headache, blurred vision, shortness of breath, nosebleeds, pounding in your neck or ears;

  • kidney problems - little or no urination, swelling in your feet or ankles, feeling tired or short of breath;

  • high potassium level - nausea, weakness, tingly feeling, chest pain, irregular heartbeats, loss of movement;

  • low potassium level - leg cramps, constipation, irregular heartbeats, fluttering in your chest, increased thirst or urination, numbness or tingling, muscle weakness or limp feeling;

  • low sodium level - headache, confusion, slurred speech, severe weakness, vomiting, loss of coordination, feeling unsteady;

  • low calcium level - muscle spasms or contractions, numbness or tingly feeling (around your mouth, or in your fingers and toes); or

  • signs of infection - fever, chills, cough, rash, swelling, diarrhea, pain or burning when you urinate.

Common Zokinvy side effects may include:

  • an electrolyte imbalance (such as low levels of potassium, sodium, or calcium in your blood);

  • infection;

  • increased blood pressure;

  • stomach pain, nausea, vomiting, diarrhea;

  • decreased appetite, weight loss;

  • headache;

  • feeling tired;

  • muscle or joint pain;

  • cold symptoms such as stuffy nose, sneezing, sore throat, cough; or

  • abnormal lab tests;

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

See more: Zokinvy Side Effects

What other drugs will affect Zokinvy?

Sometimes it is not safe to use certain medications at the same time. Some drugs can affect your blood levels of other drugs you take, which may increase side effects or make the medications less effective.

Many drugs can interact with lonafarnib. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed here. Tell your doctor about all your current medicines and any medicine you start or stop using.

More about Zokinvy (Lonafarnib [ loe-na-far-nib ])

Dosage information
Zokinvy Side Effects
During pregnancy
Zokinvy Prescribing Information
Drug images
Side effects
Drug class: Miscellaneous metabolic agents

Related treatment guides

Hutchinson-Gilford Syndrome
Share this Article
Contents
Uses Warnings Before Taking Dosage Side effects Interactions
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by